(MENAFN) Dubai's Abraaj Group said that it is pulling out from Tunisian pharmaceutical company Opalia Pharma, Arabian Business reported.
The firm said that it has sold its shares to an international pharmaceutical company called Recordati.
The Abraaj Group first invested in Opalia in 2009 in a deal that marked the Group's first realisation in the Tunisian market.
Since Then, Abraaj's involvement with the pharmaceutical company aided in doubling sales.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.